Physician profile
John J Barnes
NPI 1811007461
$3,805.93
in general payments reported to CMS, 2019-2025
34 companies · $530 in 2025
The $530 reported for 2025 was more than what 76% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $316 · 2021: $408 · 2022: $881 · 2023: $798 · 2024: $509 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,792 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,791.80 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $684.62 | 2019-2025 | Orilissa, Lo Loestrin Fe, Liletta |
| Mayne Pharma Commercial LLC | $506.98 | 2021-2025 | |
| Astellas Pharma US INC | $374.18 | 2023-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $240.72 | 2019-2024 | |
| Shield Therapeutics INC | $169.21 | 2023-2025 | |
| Exeltis, USA INC. | $164.58 | 2021-2025 | Slynd |
| Therapeuticsmd, INC. | $140.10 | 2020-2022 | |
| Aspira Women'S Health INC | $131.57 | 2021-2022 | |
| Coopersurgical, INC. | $128.34 | 2019 | |
| Hologic Sales and Service, LLC | $125.79 | 2019-2024 | Aptima |
| Biogen, INC. | $101.50 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $96.18 | 2023-2025 | Myfembree |
| Mylan Pharmaceuticals INC. | $90.60 | 2020-2022 | |
| Millicent US INC | $86.50 | 2025 | Intrarosa, Femlyv, Femring |
| Evofem Biosciences, INC. | $78.55 | 2021-2023 | Phexxi |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $71.48 | 2023-2025 | Nexplanon |
| Novo Nordisk INC | $65.57 | 2023-2025 | Wegovy |
| Allergan, INC. | $64.92 | 2019-2020 | |
| Myovant Sciences INC. | $62.54 | 2021-2022 | |
| Medline Industries LP | $62.21 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.98 | 2019-2025 | |
| Agile Therapeutics, INC. | $45.10 | 2021-2023 | Twirla |
| Duchesnay USA Incorporated | $44.75 | 2019 | |
| Roche Diagnostics Corporation | $38.52 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $34.45 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Daiichi Sankyo INC. | $22.81 | 2021 | |
| Galderma Laboratories, L.P. | $19.76 | 2024 | |
| Covidien LP | $17.68 | 2019 | |
| Sage Therapeutics, LLC | $17.64 | 2019 | |
| Alexion Pharmaceuticals, INC. | $16.81 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.33 | 2020 | |
| Lsi Solutions INC | $15.12 | 2023 | Fornisee |
| Lupin INC. | $11.96 | 2019 | |
| Avion Pharmaceuticals | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.